CN101953979A - Medicament for treating esophagitis - Google Patents

Medicament for treating esophagitis Download PDF

Info

Publication number
CN101953979A
CN101953979A CN2010102559426A CN201010255942A CN101953979A CN 101953979 A CN101953979 A CN 101953979A CN 2010102559426 A CN2010102559426 A CN 2010102559426A CN 201010255942 A CN201010255942 A CN 201010255942A CN 101953979 A CN101953979 A CN 101953979A
Authority
CN
China
Prior art keywords
parts
medicine
esophagitis
medicament
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010102559426A
Other languages
Chinese (zh)
Inventor
郝贵成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANXI TUNLIU TECHNOLOGY INFORMATION SERVICE CENTER
Original Assignee
SHANXI TUNLIU TECHNOLOGY INFORMATION SERVICE CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANXI TUNLIU TECHNOLOGY INFORMATION SERVICE CENTER filed Critical SHANXI TUNLIU TECHNOLOGY INFORMATION SERVICE CENTER
Priority to CN2010102559426A priority Critical patent/CN101953979A/en
Publication of CN101953979A publication Critical patent/CN101953979A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating esophagitis, which is prepared from platycodon root, liquorice, scutellaria, dried orange peel, pericarpium trichosanthis, longstamen onion bulb, honeysuckle, rhizoma corydalis and frank incense serving as raw materials. The medicament can be prepared into a plurality of preparations for clinical use; and components in the medicament are coordinated, a theory of diagnosis and treatment based on an overall analysis of the illness and the patient's condition is used, so that the medicament has the advantages of excellent effect on diseases, such as the esophagitis and the like, no toxic or side effect, and safe and reliable clinical use.

Description

A kind of medicine for the treatment of esophagitis
Technical field
The present invention relates to a kind of medicine for the treatment of esophagitis, specially referring to a kind of is the medicine of the treatment esophagitis of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In recent years, along with the change of people life style and dietary structure, esophagitis has become a kind of popular frequently-occurring disease.The esophagitis majority is to enter esophagus because stomach or duodenum content backflow, mucous membrane of esophagus is subjected to the stimulation of stomach middle acid substance and bile etc., its epithelial cell attenuation or come off, some the material permeance new lives' in the thing of backflowing epithelial cell and go deep into esophageal tissue causes that the inflammatory of mucous membrane of esophagus changes.Generally speaking, the reflux esophagitis majority is all simultaneously with gastritis.Esophagitis is clinical mainly to be shown as burn feeling or pain behind the brain bone, pantothenic acid, dysphagia etc.If the untimely treatment of this disease can lead to grave consequences, should cause enough attention.
The Western medicine of treatment esophagitis is a lot of at present, and the penicillin that intramuscular injection is used as anti-inflammation, streptomycin also have.Taking for a long time of these Western medicine can produce certain side effect to the organ of human body, and it is bigger to take injury for a long time.The traditional Chinese medical science advocates that dialectical executing controlled according to concrete disease, and the traditional Chinese medical science has unique effect to the treatment of this disease.
Diseases such as the similar traditional Chinese medical science pharyngalgia of primary disease, acid regurgitation.Eating and drinking without temperance, food stagnation are given birth to expectorant, or surfeit is pungent, help the stagnation of QI due to the heat fostering fire, expectorant coagulate, hot and suffocating be its main diseases because of.Prolonged illness impairment of body fluid consumption gas, it is few cloudy impairment of body fluid just can to occur, the deficiency syndrome of deficiency of vital energy superinverse.Treatment is with promoting the circulation of QI and reducing phlegm, the hot and suffocating and middle sending down the abnormal ascending QI of removing summer-heat, and it is main method that the chest stuffiness relieving is opened diaphragm.
Summary of the invention
The present invention aims to provide that a kind of therapeutic effect is good, cost is low, the medicine of the treatment esophagitis of non-evident effect.
A kind of medicine for the treatment of esophagitis of medicine of the present invention is to be that raw material is made: Radix Platycodonis, Radix Glycyrrhizae, Radix Scutellariae, Pericarpium Citri Reticulatae, Pericarpium Trichosanthis, Bulbus Allii Macrostemonis, Flos Lonicerae, Rhizoma Corydalis, Olibanum by following Chinese medicine.
The quality proportioning of each raw material is in the medicine of the present invention:
Radix Platycodonis 10-20 part, Radix Glycyrrhizae 5-15 part, Radix Scutellariae 5-15 part, Pericarpium Citri Reticulatae 5-15 part, Pericarpium Trichosanthis 5-15 part, Bulbus Allii Macrostemonis 5-15 part, Flos Lonicerae 10-20 part, Rhizoma Corydalis 5-15 part, Olibanum 5-15 part.
The quality proportioning of each raw material is in the medicine of the present invention:
15 parts of Radix Platycodoniss, 12 parts in Radix Glycyrrhizae, 12 parts of Radix Scutellariae, 12 parts of Pericarpium Citri Reticulataes, 12 parts of Pericarpium Trichosanthiss, 8 parts of Bulbus Allii Macrostemonis, 15 parts of Flos Lonicerae, 12 parts of Rhizoma Corydalis, 8 parts of Olibanums.
Medicine of the present invention can be made the multiple dosage form of clinical practice.
Each raw material pharmacology is analyzed as follows in the prescription of the present invention:
Radix Platycodonis: lung qi dispersing, eliminate the phlegm sore-throat relieving, evacuation of pus.
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication, hemostasis.
Pericarpium Citri Reticulatae: appetizing in regulating QI and lowering the adverseness, the accent, drying dampness to eliminate phlegm.
Pericarpium Trichosanthis: clearing away heat and eliminating phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, intestine moistening.
Bulbus Allii Macrostemonis: hot, bitter, warm.Return lung, stomach, large intestine channel.It mainly is an activating YANG and eliminating stagnation, and circulation of qi promoting is to stagnating.
Flos Lonicerae: cold in nature, sweet in the mouth, little hardship; GUIXIN, lung meridian.Flos Lonicerae cures mainly heat-clearing and toxic substances removing, the dispelling wind collateral dredging.
Rhizoma Corydalis: invigorate blood circulation; Dissipating blood stasis; Regulate the flow of vital energy; Pain relieving.
Olibanum: acrid in the mouth, hardship, temperature, go into the heart, liver, spleen channel.Regulating qi and activating blood, analgesic therapy chases after poison.
Medicine of the present invention effect of the present invention mainly is a removing heat-phlegm, and each component coordinated, dialectical executing are controlled in the side, and diseases such as esophagitis have been obtained better curative effect.
During treatment, this medicine every day is taken for three times.
The present invention compared with prior art has following advantage: the one, and clinical showing, this medicine prescription can improve autoimmunity and suppress further developing of esophagus inflammation, esophagitis there is better curative effect, cure rate is 85%, and effective percentage reaches 98%, obviously is better than similar recipe drug treatment.The 2nd, the misery that does not have obvious toxic-side effects to bring to the patient.The 3rd, medical expense is low, and this prescription one month was a course of treatment, and expense is 60% of congenerous disease treatment.
The specific embodiment
Below in conjunction with embodiment the present invention is described in further detail, but does not constitute any limitation of the invention.
Embodiment 1
Prepare raw material according to following weight:
Radix Platycodonis 1.5kg, Radix Glycyrrhizae 1.2kg, Radix Scutellariae 1.2kg, Pericarpium Citri Reticulatae 1.2kg, Pericarpium Trichosanthis 1.2kg, Bulbus Allii Macrostemonis 0.8kg, Flos Lonicerae 1.5kg, Rhizoma Corydalis 1.2kg, Olibanum 0.8kg.
With said herbal medicine choose clean impurity, the screening dry in the sun, the oven dry after, be ground into 80~100 order fine powders after, mix homogeneously; In Mel: medicated powder=2: 1~2 ratios, the Mel that adds capacity is put into pot and is refined, and medicated powder is added to mix in the refined honey stir evenly, close stick together, rubbing, pill.

Claims (3)

1. medicine for the treatment of esophagitis is characterized in that described medicine is is that raw material is made: Radix Platycodonis, Radix Glycyrrhizae, Radix Scutellariae, Pericarpium Citri Reticulatae, Pericarpium Trichosanthis, Bulbus Allii Macrostemonis, Flos Lonicerae, Rhizoma Corydalis, Olibanum by following Chinese medicine.
2. the medicine of treatment esophagitis according to claim 1 is characterized in that the quality proportioning of each raw material in the described medicine is:
Radix Platycodonis 10-20 part, Radix Glycyrrhizae 5-15 part, Radix Scutellariae 5-15 part, Pericarpium Citri Reticulatae 5-15 part, Pericarpium Trichosanthis 5-15 part, Bulbus Allii Macrostemonis 5-15 part, Flos Lonicerae 10-20 part, Rhizoma Corydalis 5-15 part, Olibanum 5-15 part.
3. according to the medicine of the described treatment esophagitis of claim 1, it is characterized in that the quality proportioning of each raw material in the described medicine is:
15 parts of Radix Platycodoniss, 12 parts in Radix Glycyrrhizae, 12 parts of Radix Scutellariae, 12 parts of Pericarpium Citri Reticulataes, 12 parts of Pericarpium Trichosanthiss, 8 parts of Bulbus Allii Macrostemonis, 15 parts of Flos Lonicerae, 12 parts of Rhizoma Corydalis, 8 parts of Olibanums.
CN2010102559426A 2010-08-13 2010-08-13 Medicament for treating esophagitis Pending CN101953979A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102559426A CN101953979A (en) 2010-08-13 2010-08-13 Medicament for treating esophagitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102559426A CN101953979A (en) 2010-08-13 2010-08-13 Medicament for treating esophagitis

Publications (1)

Publication Number Publication Date
CN101953979A true CN101953979A (en) 2011-01-26

Family

ID=43481735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102559426A Pending CN101953979A (en) 2010-08-13 2010-08-13 Medicament for treating esophagitis

Country Status (1)

Country Link
CN (1) CN101953979A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813711A (en) * 2012-07-27 2012-12-12 上海市中医医院 Medicine for treating gastroesophageal reflux disease and application of medicine
CN104524141A (en) * 2015-01-16 2015-04-22 覃光辉 Medicament for treating reflux esophagitis and reflux gastritis
CN104757217A (en) * 2015-04-28 2015-07-08 莫凯音 Chinese herb cold tea for preventing oesophagitis and relieving symptoms of oesophagitis
CN105395748A (en) * 2015-12-30 2016-03-16 青岛昌安达药业有限公司 Traditional Chinese medicine preparation for treating oesophagitis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813711A (en) * 2012-07-27 2012-12-12 上海市中医医院 Medicine for treating gastroesophageal reflux disease and application of medicine
CN104524141A (en) * 2015-01-16 2015-04-22 覃光辉 Medicament for treating reflux esophagitis and reflux gastritis
CN104757217A (en) * 2015-04-28 2015-07-08 莫凯音 Chinese herb cold tea for preventing oesophagitis and relieving symptoms of oesophagitis
CN105395748A (en) * 2015-12-30 2016-03-16 青岛昌安达药业有限公司 Traditional Chinese medicine preparation for treating oesophagitis

Similar Documents

Publication Publication Date Title
CN103721236B (en) A kind of Chinese medicine composition for the treatment of gastropathy
CN104352587A (en) Ointment for treating rhinitis
CN101919976A (en) Traditional Chinese medicine composition for treating mouth and tongue ulcer
CN101953979A (en) Medicament for treating esophagitis
CN103933497A (en) Chinese medicinal composition for treating constipation
CN102430091B (en) Chinese medicinal composition for treating children cough
CN103638443A (en) Traditional Chinese medicine for treating oesophagitis
CN107737330A (en) A kind of Chinese medicinal lotion for treating postpartum pain of body
CN104001131A (en) Oral traditional Chinese medicine for preventing and treating stress ulcers
CN105796891A (en) Traditional Chinese medicinal composition for treating epigastric pain
CN101822782A (en) Medicament for treating emphysema and preparation method thereof
CN102406861B (en) External medicament for treating bronchitis
CN101797291B (en) Traditional Chinese medicine for treating osteoproliferation
CN103656534A (en) Traditional Chinese medicine for treating oesophagitis
CN102247496A (en) Chinese patent drug for treating acne
CN108187023A (en) For treating the herbal composite of chronic pharyngitis
CN107961334A (en) Treat the herbal composite of chronic pharyngitis
CN103007238B (en) Traditional Chinese medicine composition for treating decubitus ulcers
CN101797316A (en) Traditional Chinese medicine for treating hyperpyrexia and infantile convulsion and preparation method thereof
CN105902766A (en) Peptic ulcer treating medicine and preparation method thereof
CN105853882A (en) Medicine for treating stomach illness and preparation method
CN104056217A (en) Traditional Chinese medicine preparation for treating geriatric cough and asthma
CN105381182A (en) Traditional Chinese medicine for treating chronic urticaria and application thereof
CN105250955A (en) Chinese herb composition for treating emphysema
CN104225009A (en) Traditional Chinese medicine composition for treating diarrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20110126